Kevin R Sayer

Executive Chair

Kevin R Sayer (Executive Chair) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in DexCom, Inc. (DXCM). The largest single filing was $2.4M of DXCM (26,659 sh across 2 lots, as filed), executed Aug 20.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.3M

shares × price, as filed

Last traded

Aug 20

Filed Aug 24

Median ADV $483.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $13.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

DXCM

DexCom, Inc. DXCM · 0 buys · 6 sells 6 filings

Recent filings

DXCMSALE DexCom, Inc. View filing → $2.4M
26,659 sh across 2 lots
Exec Aug 20
Filed Aug 24 · 4:01 PM ET DXCMSALE DexCom, Inc. View filing → $2.0M
26,756 sh × $76.32
Exec Jul 20
Filed Jul 21 · 4:58 PM ET DXCMSALE DexCom, Inc. View filing → $1.9M
26,756 sh × $72.00
Exec Jul 6
Filed Jul 7 · 4:09 PM ET DXCMSALE DexCom, Inc. View filing → $1.9M
26,759 sh × $72.00
Exec May 21
Filed May 26 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $2.3M
32,498 sh × $70.38
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $2.9M
33,359 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET